Karande Mahesh Insider Trades

Insider Trading History

Track insider trading activity for Karande Mahesh. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Omega Therapeutics
Omega Therapeutics OMGA
President And CEO
Holding Value $44.8k 314,326 shares
Last Trade
Feb 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.88M 523,877 shares
$3.59
$0.14
Omega Therapeutics
Omega Therapeutics OMGA
President And CEO
Holding Value $24.2k 170,000 shares
Last Trade
Feb 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 170,000 shares
$6.46
$0.14
Omega Therapeutics
Omega Therapeutics OMGA
President And CEO
Holding Value $24.2k 170,000 shares
Last Trade
Oct 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$896k 170,000 shares
$5.27
$0.14
Omega Therapeutics
Omega Therapeutics OMGA
President And CEO
Holding Value $48.5k 340,000 shares
Last Trade
Mar 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.52M 340,000 shares
$10.34
$0.14
Omega Therapeutics
Omega Therapeutics OMGA
President And CEO
Holding Value $126k 884,071 shares
Last Trade
Feb 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$138k 11,300 shares
$12.24
$0.14
Omega Therapeutics
Omega Therapeutics OMGA
President And CEO
Holding Value $16.8k 117,711 shares
Last Trade
Feb 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$138k 11,300 shares
$12.24
$0.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up